UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report)’s stock price rose 1% during trading on Tuesday . The stock traded as high as $273.38 and last traded at $272.2960. Approximately 5,809,206 shares changed hands during mid-day trading, a decline of 41% from the average daily volume of 9,921,009 shares. The stock had previously closed at $269.54.
Key UnitedHealth Group News
Here are the key news stories impacting UnitedHealth Group this week:
- Positive Sentiment: Company push into AI and efficiency gains — UNH emphasized expanded AI investments and operational improvements at its recent conference and reiterated its growth/earnings outlook, supporting near-term confidence in margins if initiatives scale as planned. UnitedHealth (UNH) Expands AI Investments to Boost Efficiency
- Positive Sentiment: Market commentary arguing fears are overblown — analysis from market commentators frames recent sell-offs as exaggerated versus UNH’s diversified model and stable cash generation, which can attract long-term investors at lower multiples. UnitedHealth Group: Fears Remain Overblown
- Neutral Sentiment: Wall Street rating overview — Coverage pieces review analyst views and consensus recommendations; this context helps explain volatility when downgrades or target cuts hit but does not itself change fundamentals. Is It Worth Investing in UnitedHealth (UNH) Based on Wall Street’s Bullish Views?
- Neutral Sentiment: Industry comparisons and upside debate — Analysts contrast UNH’s consistency with peers (e.g., Centene), useful for relative-value decisions but not an immediate catalyst. The Upside Debate: UnitedHealth’s Consistency vs. Centene’s Comeback
- Negative Sentiment: DOJ antitrust escalation — The Justice Department has intensified its probe into how Optum interacts with UnitedHealth’s insurance business, raising regulatory and structural-risk concerns that can pressure valuation and deal activity. DOJ Antitrust Probe Puts Focus On UnitedHealth Valuation And Integrated Model
- Negative Sentiment: Analyst downgrades and earnings estimate cuts — Recent coverage highlights downgrades and a pessimistic earnings revision from Zacks, which contribute to the stock’s 2026 weakness and can weigh on sentiment until guidance/earnings prove resilient. UnitedHealth (UNH) Stock Faces Pressure from Analyst Downgrades and Regulatory Challenges
- Negative Sentiment: Financial performance/cost pressure narrative — Coverage noting an expanding gap between reimbursement rates and medical expenses underscores near-term margin risk and helps explain the stock’s pullback year-to-date. UnitedHealth Stock Is Down 18% in 2026 and Keeps Stumbling
Analysts Set New Price Targets
Several research analysts recently commented on the stock. Evercore upgraded shares of UnitedHealth Group to a “strong-buy” rating in a research note on Tuesday, January 6th. Truist Financial cut their target price on UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating on the stock in a research report on Monday, February 2nd. JPMorgan Chase & Co. reduced their target price on shares of UnitedHealth Group from $425.00 to $389.00 and set an “overweight” rating for the company in a report on Monday, February 2nd. Wells Fargo & Company cut their price target on UnitedHealth Group from $400.00 to $370.00 and set an “overweight” rating on the stock in a research report on Friday, January 30th. Finally, Oppenheimer lowered their target price on UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating on the stock in a research note on Wednesday, January 28th. One analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $372.13.
UnitedHealth Group Stock Up 1.0%
The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.79. The company has a market cap of $247.16 billion, a PE ratio of 20.64, a PEG ratio of 1.27 and a beta of 0.41. The business’s fifty day simple moving average is $295.77 and its two-hundred day simple moving average is $324.10.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, beating the consensus estimate of $2.09 by $0.02. The firm had revenue of $113.73 billion during the quarter, compared to analyst estimates of $113.38 billion. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.UnitedHealth Group’s revenue for the quarter was up 12.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $6.81 EPS. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were paid a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.2%. UnitedHealth Group’s payout ratio is currently 67.02%.
Hedge Funds Weigh In On UnitedHealth Group
A number of hedge funds have recently made changes to their positions in the company. Guerra Advisors Inc acquired a new stake in shares of UnitedHealth Group in the third quarter worth $1,059,000. Berkshire Hathaway Inc purchased a new stake in UnitedHealth Group during the 2nd quarter worth $1,572,193,000. Carnegie Investment Counsel raised its position in UnitedHealth Group by 2.2% in the third quarter. Carnegie Investment Counsel now owns 105,621 shares of the healthcare conglomerate’s stock valued at $36,471,000 after purchasing an additional 2,316 shares during the period. EverSource Wealth Advisors LLC boosted its position in shares of UnitedHealth Group by 48.9% in the second quarter. EverSource Wealth Advisors LLC now owns 5,790 shares of the healthcare conglomerate’s stock worth $1,806,000 after buying an additional 1,901 shares during the period. Finally, Phoenix Financial Ltd. raised its stake in shares of UnitedHealth Group by 111.5% during the third quarter. Phoenix Financial Ltd. now owns 41,986 shares of the healthcare conglomerate’s stock valued at $14,282,000 after purchasing an additional 22,137 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
See Also
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
